Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1984 Sep-Oct;12(5):322-7.
doi: 10.1007/BF01651145.

Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells

Comparative Study

Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells

P C Fink et al. Infection. 1984 Sep-Oct.

Abstract

The effect of lipopolysaccharides (LPS), lipid A and interferon on cell-mediated cytotoxicity was investigated using 51Cr-labeled K-562 tumor cells as targets. As effectors, peripheral blood mononuclear cells from healthy blood donors were obtained by Ficoll gradient centrifugation: mononuclear phagocytes were eliminated by iron phagocytosis and plastic adherence. A T cell-enriched population was obtained by passing mononuclear phagocyte-depleted mononuclear cells through nylon wool columns. LPS and lipid A augmented cell-mediated cytotoxicity provided mononuclear phagocytes were present. Supernatants from LPS-treated mononuclear phagocytes and T cells enhanced mononuclear phagocyte-mediated cytotoxicity to a higher degree than LPS and lipid A alone. This finding suggests the participation of a lymphokine. In contrast, the interferon preparation increased the cell-mediated cytotoxicity both of mononuclear phagocyte-containing and of mononuclear phagocyte-depleted effectors. Here, the participation of natural killer cells as effectors is suggested.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Immunol. 1977;6(3):173-83 - PubMed
    1. J Immunol. 1978 Jul;121(1):72-80 - PubMed
    1. J Exp Med. 1973 Oct 1;138(4):784-97 - PubMed
    1. J Immunol. 1980 Oct;125(4):1650-7 - PubMed
    1. Cancer Res. 1946 Apr;6:205-16 - PubMed

Publication types

LinkOut - more resources